Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Gautschi

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Clinical Lung Cancer|March 5, 2010
The polyamine metabolism: renaissance of an old pathway in oncologyOliver Gautschi
Revue Medicale Suisse|January 31, 2018
Oliver Gautschi
JTO Clinical and Research Reports|September 30, 2021
Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With <i>EGFR</i> and <i>MET</i>-Driven Lung Cancer: Case ReportOliver Gautschi, Joachim Diebold
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Advances in the treatment of RET-fusion-positive lung cancerGeorg Pall, Oliver Gautschi
Cancer Letters|January 28, 2004
Comment on "Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-call lung cancer patients" (Cancer Letters 2003;193:207-216)Oliver Gautschi, Annemarie Ziegler
Clinical Lung Cancer|June 28, 2006
Clinical development of SRC tyrosine kinase inhibitors in lung cancerDavid Lee, Oliver Gautschi
Clinical Lung Cancer|June 25, 2013
Crizotinib in the treatment of non--small-cell lung cancerSacha I Rothschild, Oliver Gautschi
Translational Lung Cancer Research|July 10, 2023
Divide and conquer: towards isoform-specific diagnosis and therapy of <i>KRAS</i>-mutant lung cancerAnna T Allemann, Oliver Gautschi
Current Opinion in Oncology|November 6, 2018
Treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: update and perspectivesChristoph Oliver Ryser, Joachim Diebold, Oliver Gautschi
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 29, 2015
Successful AZD9291 Therapy Based on Circulating T790MOliver Gautschi, Stefan Aebi, Lukas C Heukamp
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Clinical Lung Cancer|March 5, 2010
The polyamine metabolism: renaissance of an old pathway in oncologyOliver Gautschi
Revue Medicale Suisse|January 31, 2018
Oliver Gautschi
JTO Clinical and Research Reports|September 30, 2021
Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With <i>EGFR</i> and <i>MET</i>-Driven Lung Cancer: Case ReportOliver Gautschi, Joachim Diebold
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Advances in the treatment of RET-fusion-positive lung cancerGeorg Pall, Oliver Gautschi
Cancer Letters|January 28, 2004
Comment on "Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-call lung cancer patients" (Cancer Letters 2003;193:207-216)Oliver Gautschi, Annemarie Ziegler
Clinical Lung Cancer|June 28, 2006
Clinical development of SRC tyrosine kinase inhibitors in lung cancerDavid Lee, Oliver Gautschi
Clinical Lung Cancer|June 25, 2013
Crizotinib in the treatment of non--small-cell lung cancerSacha I Rothschild, Oliver Gautschi
Translational Lung Cancer Research|July 10, 2023
Divide and conquer: towards isoform-specific diagnosis and therapy of <i>KRAS</i>-mutant lung cancerAnna T Allemann, Oliver Gautschi
Current Opinion in Oncology|November 6, 2018
Treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: update and perspectivesChristoph Oliver Ryser, Joachim Diebold, Oliver Gautschi
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 29, 2015
Successful AZD9291 Therapy Based on Circulating T790MOliver Gautschi, Stefan Aebi, Lukas C Heukamp
Pageof 11